{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:33:22Z","timestamp":1787510002093,"version":"build-2736575974"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Overexpression of the transcription factor NR5A1 and constitutive activation of canonical Wnt signalling leading to nuclear translocation of beta-catenin are hallmarks of malignancy in adrenocortical carcinoma (ACC). Based on the analysis of genomic profiles in H295R ACC cells, Mohan et\u00a0al. (\n                      <jats:italic>Cancer Res<\/jats:italic>\n                      . 2023; 83: 2123-2141) recently suggested that a major determinant driving proliferation and differentiation in malignant ACC is the interaction of NR5A1 and beta-catenin on chromatin to regulate gene expression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>I reanalyzed the same set of data generated by Mohan et\u00a0al. and other published data of knockdown-validated NR5A1 and beta-catenin target genes,<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Beta-catenin is mainly found in association to canonical T cell factor\/lymphoid enhancer factor (TCF\/LEF) motifs in genomic DNA. NR5A1 and beta-catenin regulate distinct target gene sets in ACC cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Overall, my analysis suggests a model where NR5A1 overexpression and beta-catenin activation principally act independently, rather than functionally interacting, to drive ACC malignancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2023.1303332","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T06:15:40Z","timestamp":1702016140000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["A reappraisal of transcriptional regulation by NR5A1 and beta-catenin in adrenocortical carcinoma"],"prefix":"10.3389","volume":"14","author":[{"given":"Enzo","family":"Lalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2006.01.022","article-title":"SF-1 overexpression in childhood adrenocortical tumours","volume":"42","author":"Pianovski","year":"2006","journal-title":"Eur J Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0653","article-title":"High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors","volume":"95","author":"Sbiera","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/me.2007-0120","article-title":"Increased Steroidogenic Factor-1 dosage triggers adrenocortical cell proliferation and cancer","volume":"21","author":"Doghman","year":"2007","journal-title":"Mol Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0342","article-title":"Nephroblastoma overexpressed\/cysteine-rich protein 61\/connective tissue growth factor\/nephroblastoma overexpressed gene-3 (NOV\/CCN3), a selective adrenocortical cell proapoptotic factor, is down-regulated in childhood adrenocortical tumors","volume":"92","author":"Doghman","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt658","article-title":"Integrative analysis of SF-1 transcription factor dosage impact on genome-wide binding and gene expression regulation","volume":"41","author":"Doghman","year":"2013","journal-title":"Nucl Acids Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201541504","article-title":"FATE1 antagonizes calcium- and drug-induced apoptosis by uncoupling ER and mitochondria","volume":"17","author":"Doghman-Bouguerra","year":"2016","journal-title":"EMBO Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aal2464","article-title":"Dosage-dependent regulation of VAV2 expression by Steroidogenic Factor-1 drives adrenocortical carcinoma cell invasion","volume":"10","author":"Ruggiero","year":"2017","journal-title":"Sci Signal"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043585","article-title":"Steroidogenic Factor 1, a Goldilocks transcription factor from adrenocortical organogenesis to Malignancy","volume":"24","author":"Relav","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2010.11.014","article-title":"Lalli E 2011 The Wnt\/beta-catenin pathway in adrenocortical development and cancer","volume":"332","author":"El Wakil","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assi\u00e9","year":"2014","journal-title":"Nat Genet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01348","article-title":"Targeted molecular analysis in adrenocortical carcinomas: a strategy toward improved personalized prognostication","volume":"103","author":"Lippert","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-2006","article-title":"\u03b2-catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma","volume":"17","author":"Gaujoux","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M212677200","article-title":"Convergence of Wnt signaling and steroidogenic factor-1 (SF-1) on transcription of the rat inhibin alpha gene","volume":"278","author":"Gummow","year":"2003","journal-title":"J Biol Chem"},{"key":"B14","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.molcel.2004.07.009","article-title":"Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation","volume":"15","author":"Botrugno","year":"2004","journal-title":"Mol Cell"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/embj.201385358","article-title":"Wnt-induced transcriptional activation is exclusively mediated by TCF\/LEF","volume":"33","author":"Schuijers","year":"2014","journal-title":"EMBO J"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2015.20","article-title":"Combined transcriptome studies identify AFF3 as a mediator of the oncogenic effects of \u03b2-catenin in adrenocortical carcinoma","volume":"4","author":"Lef\u00e8vre","year":"2015","journal-title":"Oncogenesis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-2712","article-title":"\u03b2-catenin-driven differentiation is a tissue-specific epigenetic vulnerability in adrenal cancer","volume":"83","author":"Mohan","year":"2023","journal-title":"Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa434","article-title":"The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2020 update","volume":"48","author":"Jalili","year":"2020","journal-title":"Nucl Acids Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv416","article-title":"The MEME suite","volume":"43","author":"Bailey","year":"2015","journal-title":"Nucl Acids Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-2021","article-title":"Sterol O-acyltransferase 1 (SOAT1, ACAT) is a novel target of Steroidogenic Factor-1 (SF-1, NR5A1, Ad4BP) in the human adrenal","volume":"96","author":"Ferraz-de-Souza","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032080","article-title":"Knockdown of SF-1 and RNF31 affects components of steroidogenesis, TGF\u03b2, and Wnt\/\u03b2-catenin signaling in adrenocortical carcinoma cells","volume":"7","author":"Ehrlund","year":"2012","journal-title":"PloS One"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-15-293","article-title":"jvenn: an interactive Venn diagram viewer","volume":"15","author":"Bardou","year":"2014","journal-title":"BMC Bioinf"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/me.2002-0362","article-title":"Dax-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X chromosome, gene 1) gene transcription is regulated by wnt4 in the female developing gonad","volume":"17","author":"Mizusaki","year":"2003","journal-title":"Mol Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/me.2010-0503","article-title":"StarD7 gene expression in trophoblast cells: contribution of SF-1 and Wnt-beta-catenin signaling","volume":"25","author":"Rena","year":"2011","journal-title":"Mol Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0247","article-title":"The T cell factor\/beta-catenin antagonist PKF115-584 inhibits proliferation of adrenocortical carcinoma cells","volume":"93","author":"Doghman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055743","article-title":"Silencing mutated \u03b2-catenin inhibits cell proliferation and stimulates apoptosis in the adrenocortical cancer cell line H295R","volume":"8","author":"Gaujoux","year":"2013","journal-title":"PloS One"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5513","article-title":"Inhibition of the Tcf\/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis","volume":"6","author":"Leal","year":"2015","journal-title":"Oncotarget"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3222","article-title":"Loss of \u03b2-catenin in adrenocortical cancer cells causes growth inhibition and reversal of epithelial-to-mesenchymal transition","volume":"6","author":"Salomon","year":"2015","journal-title":"Oncotarget"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S159979","article-title":"\u03b2-Catenin-driven adrenocortical carcinoma is characterized with immune exclusion","volume":"11","author":"Liu","year":"2018","journal-title":"Onco Targets Ther"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34526","article-title":"FSCN1 as a new druggable target in adrenocortical carcinoma","volume":"153","author":"Ruggiero","year":"2023","journal-title":"Int J Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2163","article-title":"Inhibition of adrenocortical carcinoma cell proliferation by Steroidogenic Factor-1 inverse agonists","volume":"94","author":"Doghman","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2174\/1568026623666230303101810","article-title":"Wnt\/\u03b2-catenin signaling inhibitors","volume":"23","author":"Zhang","year":"2023","journal-title":"Curr Top Med Chem"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1303332\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T06:15:51Z","timestamp":1702016151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1303332\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,8]]},"references-count":33,"alternative-id":["10.3389\/fendo.2023.1303332"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1303332","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,8]]},"article-number":"1303332"}}